Key Drivers
- Margin Compression
- Liquidity Decline
- Rising Leverage
AIAI Summary
SOLV is a “prove-it” recovery: upside depends on converting improving organic growth and gross margins into recurring free cash flow and debt reduction, while the HIS separation could unlock value but materially raises near-term margin, liquidity, and execution risk—investors should wait for sustained reported profitability and deleveraging evidence.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Compression
- •Liquidity Decline
- •Rising Leverage
SOLV's strong 2025 profitability has weakened sharply in the latest quarter, with falling margins, liquidity, and rising leverage making operational recovery essential despite moderate valuation.
Price Behavior
Key Price Behavior Insights:
- •Support holding
- •Momentum weak
- •Breakout needed
SOLV is weak below $90.14 but holding $87.45–$87.65 support; a break below support risks further downside, while sustained closes above $90.10 would improve momentum.
Rebounded from support to $88.84 but remains below key resistance
Sentiment & News
Key News Insights:
- •Raised guidance
- •Margin expansion
- •Debt concerns
Solventum's raised guidance, margin gains and potential spin-off strengthen its outlook, though debt and cost pressures remain key risks.
The news is moderately positive for Solventum, but leverage could constrain valuation upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings